Редкий случай макулярной телеангиэктазии 1-го типа у ребенка

    1. Nowilaty SR, Al-Shamsi HN, Al-Khars W. Idiopathic juxtafoveolar retinal telangiectasis: a current review. Middle East Afr J Ophthalmol. 2010;17: 224–241.

    2. Powner MB, Gillies MC, Tretiach M, Scott A, Guymer RH, Hageman GS, Fruttiger M. Perifoveal muller cell depletion in a case of macular telangiectasia type 2. Ophthalmology. 2010;117(12): 2407–2416. doi: 10.1016/j.ophtha.2010.04.001

    3. Baz O, Yilmaz I, Alagoz C, Demircan A, Perente I, Ozkaya A, Taskapili M. Efficacy of Intravitreal Bevacizumab in Treatment of Proliferative Type 2 Idiopathic Juxtafoveal Telangiectasia. Turk J Ophthalmol. 2017;47(3): 144–148. doi: 10.4274/tjo.04874

    4. Wu L, Evans T, Arevalo JF. Idiopathic macular telangiectasia type 2 (idiopathic juxtafoveolar retinal telangiectasis type 2A, Mac Tel 2). SurvOphthalmol. 2013;58: 536–559.

    5. Gass J, Blodi B. Idiopathic juxtafoveolar retinal telangiectasis: update of classification and follow-up study. Ophthalmology. 1993;100(10): 1536–1546.

    6. Gass J, Oyakawa R. Idiopathic juxtafoveolar retinal telangiectasis. Arch Ophthalmol. 1982;100(5): 769–780.

    7. Терещенко А.В., Трифаненкова И.Г., Ерохина Е.В. Возможности ОСТ-ангиографии в диагностике макулярных телеангиэктазий 2-го типа Практическая медицина. 2017;9(110): 227–234. [Tereshchenko AV, Trifanenkova IG, Erokhina EV. Vozmozhnosti OST-angiografii v diagnostike makulyarnykh teleangiektaziy 2-go tipa Prakticheskaya meditsina. 2017;9(110): 227-234. (In Russ.)]

    8. Wong WT, Forooghian F. Majumdar Z, et. al. Fundus autofluorescence in type 2 idiopathic macular telangiectasia: correlation with optical coherence tomography and microperimetry. Am J Ophthalmol. 2009;148(4): 573–583.

    9. Sallo FB, Leung I, Clemons TE, et. al. Multimodal imaging in type 2 idiopathic macular telangiectasia. Retina. 2015;35: 742–749.

    10. Park DW, Schatz H, McDonald HR, Johnson RN. Grid laser photocoagulation for macular edema in bilateral juxtafoveal telangiectasis. Ophthalmology. 1997;104(11): 1838–1846.

    11. Alldredge CD, Garretson BR. Intravitreal triamcinolone for the treatment of idiopathic juxtafoveal telangiectasis. Retina. 2003;23: 113–116.

    12. Raza S, Toklu Y, Anayol MA, Simsek S, Ozkan B, Altintas AK. Comparison between efficacy of triamcinolone acetonide and bevacizumab in a case with type 2A idiopathic parafoveal telangiectasia. Turk J Ophthalmol. 2011;41(1): 6–9.

    13. Roller AB, Folk JC, Patel NM, Boldt HC, Russell SR, Abramoff MD, Mahajan VB. Intravitreal bevacizumab for treatment of proliferative and nonproliferative type 2 idiopathic macular telangiectasia. Retina. 2011;31: 1848–1855.